ConductScience.org, home

Paper40596223

Single-dose radiotherapy is more effective than fractionation when combined with anti-PD-1 immunotherapy in glioblastoma.

Cocito C and 5 others. Sci Rep, 2025. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. Single-dose radiotherapy is more effective than fractionation when combined with anti-PD-1 immunotherapy in glioblastoma. Papers, record 40596223. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40596223

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Single-dose radiotherapy is more effective than fractionation when combined with anti-PD-1 immunotherapy in glioblastoma.
PubMed
Journal
Sci Rep
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
2.03, provisional
iCite
Revised in PubMed
2026-09-24
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cocito CCarolina
2Branchtein MMylene
3Zhou XKXi Kathy
4Gongora TTatyana
5Dahmane NNadia
6Greenfield JPJeffrey Peter

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GlioblastomaMajor topic
Brain NeoplasmsMajor topic
ImmunotherapyMajor topic
Immune Checkpoint InhibitorsMajor topic
Programmed Cell Death 1 ReceptorMajor topic
Animals
Mice
Cell Line, Tumor
Dose Fractionation, Radiation
Tumor Microenvironment
Humans
Combined Modality Therapy
Disease Models, Animal
Mice, Inbred C57BL
Cell Proliferation

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
UL1 TR001873NCATS NIH HHSUnited StatesUL1TR001873PubMedNIH RePORTER
UL1 TR002384NCATS NIH HHSUnited StatesUL1TR002384PubMed and NIHNIH RePORTER
UL1TR002384NCATS NIH HHSUnited StatesUL1TR002384PubMed and NIHNIH RePORTER

Download CSV of grants

References67

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117051156Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.Nature2006https://conductscience.org/library/papers/17051156PubMed
224045166
Elevated CD3+ and CD8+ tumor-infiltrating immune cells correlate with prolonged survival in glioblastoma patients despite integrated immunosuppressive mechanisms in the tumor microenvironment and at the systemic level.
J Neuroimmunol2013https://conductscience.org/library/papers/24045166PubMed
325408172The soft agar colony formation assay.J Vis Exp2014https://conductscience.org/library/papers/25408172PubMed
422483738Phase II trial of hypofractionated IMRT with temozolomide for patients with newly diagnosed glioblastoma multiforme.Int J Radiat Oncol Biol Phys2012https://conductscience.org/library/papers/22483738PubMed
528598415DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity.Nat Commun2017https://conductscience.org/library/papers/28598415PubMed
616972896CNS immune privilege: hiding in plain sight.Immunol Rev2006https://conductscience.org/library/papers/16972896PubMed
727532020A hypofractionated radiation regimen avoids the lymphopenia associated with neoadjuvant chemoradiation therapy of borderline resectable and locally advanced pancreatic adenocarcinoma.J Immunother Cancer2016https://conductscience.org/library/papers/27532020PubMed
823462419Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas.Int J Radiat Oncol Biol Phys2013https://conductscience.org/library/papers/23462419PubMed
926406148Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma.N Engl J Med2015https://conductscience.org/library/papers/26406148PubMed
1032968155Molecular subtyping of glioblastoma based on immune-related genes for prognosis.Sci Rep2020https://conductscience.org/library/papers/32968155PubMed
1127358487Combination Therapy with Anti-PD-1, Anti-TIM-3, and Focal Radiation Results in Regression of Murine Gliomas.Clin Cancer Res2017https://conductscience.org/library/papers/27358487PubMed
1225053711Epidemiologic and molecular prognostic review of glioblastoma.Cancer Epidemiol Biomarkers Prev2014https://conductscience.org/library/papers/25053711PubMed
1331238970Optimized fractionated radiotherapy with anti-PD-L1 and anti-TIGIT: a promising new combination.J Immunother Cancer2019https://conductscience.org/library/papers/31238970PubMed
1431815646Immune landscapes associated with different glioblastoma molecular subtypes.Acta Neuropathol Commun2019https://conductscience.org/library/papers/31815646PubMed
1517440099Gene expression profiling of breast, prostate, and glioma cells following single versus fractionated doses of radiation.Cancer Res2007https://conductscience.org/library/papers/17440099PubMed
1632437507Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical Trial.JAMA Oncol2020https://conductscience.org/library/papers/32437507PubMed
1724777500Concurrent radiotherapy and ipilimumab immunotherapy for patients with melanoma.Cancer Immunol Res2013https://conductscience.org/library/papers/24777500PubMed
1816580493Hypofractionated high-dose irradiation for the treatment of malignant astrocytomas using simultaneous integrated boost technique by IMRT.Int J Radiat Oncol Biol Phys2006https://conductscience.org/library/papers/16580493PubMed
1925855793Human DNA Exonuclease TREX1 Is Also an Exoribonuclease That Acts on Single-stranded RNA.J Biol Chem2015https://conductscience.org/library/papers/25855793PubMed
2028697342Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment.Cancer Cell2017https://conductscience.org/library/papers/28697342PubMed

See all 67 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
42375374Meningeal immunity and "Interstitial" therapy: a new paradigm for immunotherapy in glioblastoma.Front Immunol2026https://conductscience.org/library/papers/42375374PubMed
42196502The Double-Edged Sword: How Radiotherapy Shapes the Tumor Immune Microenvironment to Modulate Responses to Checkpoint Inhibitors.Int J Mol Sci2026https://conductscience.org/library/papers/42196502PubMed
42038016Myeloid-Derived Suppressor Cells and Radiotherapy: Regulation and Clinical Implications.J Cancer2026https://conductscience.org/library/papers/42038016PubMed
41974019IL6 Supports Development of an Immunosuppressive Microenvironment and Resistance to Therapy in Glioblastoma.Cancer Res2026https://conductscience.org/library/papers/41974019PubMed
41892350Precision Immunotherapeutics for Glioblastoma: Current Approaches and Emerging Strategies in 2026.Cells2026https://conductscience.org/library/papers/41892350PubMed
41403943A case report of advanced pancreatic neuroendocrine carcinoma with Ki67 80%, CPS 0, and pMMR achieving durable complete response for over 7 years after combination immunotherapy.Front Immunol2025https://conductscience.org/library/papers/41403943PubMed
41374979Immunotherapy for Glioblastoma: A Focus on PD-1/PD-L1 Inhibitors.Cancers (Basel)2025https://conductscience.org/library/papers/41374979PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
PDCD15133PubTator's text mininghttps://conductscience.org/library/genes/5133

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40596223

GET https://conductscience.org/api/papers/v1/40596223/references?page=2